Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T08741 | Target Info | |||
| Target Name | Tyrosine-protein kinase CSK (CSK) | ||||
| Synonyms | Protein-tyrosine kinase CYL; C-Src kinase | ||||
| Target Type | Patented-recorded Target | ||||
| Gene Name | CSK | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US9278100 | ||||
| Title | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors | ||||
| Abstract | Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors. | ||||
| Applicant(s) | Pharmacyclics LLC | ||||
| Representative Drug(s) | D02DJP | Drug Info | IC50 = 2.4 nM | [1] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors. US9278100. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.